Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 8/20 | 0.35 |
| ▸ | PPARD | Q03181 | 6/20 | 0.35 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | GYS1 | P13807 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16442779 | 0.92 | FFAR1 (0.37) | FFAR1MAOBSLC22A12MAOAALDH1A1 | |
| SCHEMBL16206156 | 0.92 | FFAR1 (0.38) | FFAR1PPARDSLC22A12FFAR4GYS1 | |
| SCHEMBL17614595 | 0.92 | FFAR1 (0.34) | FFAR1PPARDMAOBSLC22A12MAOA | |
| SCHEMBL17614581 | 0.91 | GYS1 (0.38) | FFAR1PPARDMAOBSLC22A12MAOA | |
| SCHEMBL17615395 | 0.90 | FFAR1 (0.41) | FFAR1PPARDMAOBSLC22A12GYS1 | |
| SCHEMBL17614548 | 0.90 | SLC22A12 (0.42) | FFAR1MAOBSLC22A12MAOAALDH1A1 | |
| SCHEMBL16205972 | 0.88 | GYS1 (0.39) | FFAR1PPARDALDH1A1GYS1 | |
| SCHEMBL17614619 | 0.88 | MAOA (0.44) | MAOBSLC22A12MAOAALDH1A1 | |
| SCHEMBL16205976 | 0.87 | GYS1 (0.42) | FFAR1PPARDGYS1GRM5 | |
| SCHEMBL17614583 | 0.87 | GYS1 (0.36) | FFAR1MAOBSLC22A12MAOAGYS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9867372-B2 | Tetrazolinone compound and use of same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20160081339-A1 | TETRAZOLINONE COMPOUND AND USE OF SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160081339-A1 | TETRAZOLINONE COMPOUND AND USE OF SAME | MT-CO1, SOD1, MT-CO2 | FFAR1 1688/4885PPARD 2520/4885MAOB 1360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.